LH - Laboratory Corporation of America Holdings

NYSE - NYSE Delayed Price. Currency in USD
172.15
-1.09 (-0.63%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close173.24
Open173.62
Bid172.18 x 1000
Ask172.22 x 1200
Day's Range172.06 - 174.46
52 Week Range119.38 - 185.76
Volume446,404
Avg. Volume741,384
Market Cap16.957B
Beta (3Y Monthly)1.04
PE Ratio (TTM)19.53
EPS (TTM)8.81
Earnings DateJul 25, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date1994-03-29
1y Target Est183.61
Trade prices are not sourced from all markets
  • Will LabCorp's (LH) Q2 Earnings Gain From Overall Growth?
    Zacks21 hours ago

    Will LabCorp's (LH) Q2 Earnings Gain From Overall Growth?

    Within Covance Drug Development, LabCorp (LH) is focused on driving profitable growth through expanded solutions and enhanced operational capabilities.

  • Business Wire22 hours ago

    LabCorp Expands Consumer-Initiated Test Offering

    LabCorp® (LH), a leading global life sciences company, today announced a significant expansion to its Pixel by LabCorp™ platform. The new offering allows consumers to purchase testing online, visit a convenient LabCorp patient service center (PSC) for specimen collection by a LabCorp phlebotomist, and receive confidential results through a secure online portal. The tests are performed in LabCorp’s laboratories, using the same equipment and processes as the testing that clinicians order for their patients during in-office visits.

  • LabCorp (LH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
    Zacks5 days ago

    LabCorp (LH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

    LabCorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • LH vs. CNMD: Which Stock Is the Better Value Option?
    Zacks6 days ago

    LH vs. CNMD: Which Stock Is the Better Value Option?

    LH vs. CNMD: Which Stock Is the Better Value Option?

  • Another 2.2 million patients affected by AMCA data breach
    TechCrunch6 days ago

    Another 2.2 million patients affected by AMCA data breach

    Another clinical lab ensnared in the AMCA data breach has come forward. Clinical Pathology Laboratories (CPL) says 2.2 million patients may have had their names, addresses, phone numbers, dates of birth, dates of service, balance information and treatment provider information stolen in the previously reported breach. Another 34,500 patients had their credit card or banking information compromised.

  • GuruFocus.com13 days ago

    Laboratory Corp Of America Holdings (LH) CFO, EVP Glenn A Eisenberg Sold $983,260 of Shares

    CFO, EVP of Laboratory Corp Of America Holdings (LH) Glenn A Eisenberg sold 5,563 shares of LH on 07/08/2019 at an average price of $176.75 a share.

  • Markit14 days ago

    See what the IHS Markit Score report has to say about Laboratory Corporation of America Holdings.

    Laboratory Corporation of America Holdings NYSE:LHView full report here! Summary * Perception of the company's creditworthiness is negative * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for LH with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting LH. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.64 billion over the last one-month into ETFs that hold LH are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. LH credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Why Laboratory Corporation of America Holdings's (NYSE:LH) CEO Pay Matters To You
    Simply Wall St.19 days ago

    Why Laboratory Corporation of America Holdings's (NYSE:LH) CEO Pay Matters To You

    Dave King has been the CEO of Laboratory Corporation of America Holdings (NYSE:LH) since 2007. This report will...

  • Business Wire22 days ago

    Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

    LabCorp® (LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject to the terms of the Zero Coupon Notes and the Indenture, dated as of Oct. 24, 2006, between LabCorp and The Bank of New York Mellon, as trustee (Trustee) and the conversion agent.

  • PR Newswire22 days ago

    Miraca and Seventh Sense Biosystems, Inc. Announce Strategic Investment and Distribution Agreement

    MEDFORD, Mass. and TOKYO , July 1, 2019 /PRNewswire/ -- Seventh Sense Biosystems, Inc. (7SBio), makers of TAP™, the world's first push-button blood collection device, and Miraca Holdings Inc. or Miraca ($MRCHF), ...

  • Business Wire28 days ago

    LabCorp to Announce Second Quarter Financial Results on July 25, 2019

    LabCorp® (LH) will release its second quarter of 2019 financial results before the market opens on Thursday, July 25, 2019, followed by a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results. Interested parties can access the conference call by dialing 844-634-1444 within the U.S. and Canada, or 1-615-247-0253 internationally, using the passcode 9679477. An audio replay of the conference call will be available from 1:00 p.m. EDT on July 25, 2019, until 11:30 a.m. EDT on August 8, 2019, by dialing 855-859-2056 within the U.S. and Canada, or 1-404-537-3406 internationally, using the passcode 9679477.

  • Will Pharmacy International Hit Walgreens (WBA) Q3 Earnings?
    Zacks29 days ago

    Will Pharmacy International Hit Walgreens (WBA) Q3 Earnings?

    Challenging market conditions, especially in retail, causes a slowdown in the Retail Pharmacy International division at Walgreens Boots (WBA).

  • Triad firm partners with New York-based health system on AI
    American City Business Journalslast month

    Triad firm partners with New York-based health system on AI

    The artificial intelligence being shared with New York City's largest health system, Mount Sinai, has already been implemented in four of LabCorp's laboratories.

  • Business Wirelast month

    LabCorp and Mount Sinai Health System Collaborate to Establish Digital and AI-Enabled Pathology Center of Excellence

    LabCorp® (LH) and the Mount Sinai Health System today announced another element in their shared goal of improving laboratory services and patient care. LabCorp, a leading global life sciences company, and Mount Sinai, New York City's largest integrated healthcare delivery system, will work together to establish the Mount Sinai Digital and Artificial Intelligence (AI)-Enabled Pathology Center of Excellence.

  • LabCorp Diagnostics Shows Robust Growth Amid Price Declines
    Zackslast month

    LabCorp Diagnostics Shows Robust Growth Amid Price Declines

    LabCorp's (LH) Diagnostics business sees an organic uptick in terms of both revenues and volumes in spite of further price reductions.

  • Zacks.com featured highlights include: Starbucks, T. Rowe Price, Laboratory Corporation, Carlisle and FleetCor
    Zackslast month

    Zacks.com featured highlights include: Starbucks, T. Rowe Price, Laboratory Corporation, Carlisle and FleetCor

    Zacks.com featured highlights include: Starbucks, T. Rowe Price, Laboratory Corporation, Carlisle and FleetCor

  • Here’s What Hedge Funds Think About Laboratory Corp. of America Holdings (LH)
    Insider Monkeylast month

    Here’s What Hedge Funds Think About Laboratory Corp. of America Holdings (LH)

    A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]

  • Robust Sales Growth Makes These 5 Stocks Worth Buying Now
    Zackslast month

    Robust Sales Growth Makes These 5 Stocks Worth Buying Now

    Sales growth provides investors an insight into product demand and pricing power.

  • LH vs. XRAY: Which Stock Is the Better Value Option?
    Zackslast month

    LH vs. XRAY: Which Stock Is the Better Value Option?

    LH vs. XRAY: Which Stock Is the Better Value Option?

  • Business Wire2 months ago

    LabCorp and QIAGEN Announce New therascreen PIK3CA Mutation Analysis Companion Diagnostic for Metastatic Breast Cancer

    LabCorp® (LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced a new companion diagnostic called therascreen® PIK3CA PCR mutation analysis, which is now available through LabCorp and its Integrated Oncology specialty laboratory. The test, developed by QIAGEN (NYSE: QGEN, Frankfurt Stock Exchange: QIA), a world leader in Sample to Insight solutions for molecular testing, identifies whether a patient has the specific gene mutation that is a prerequisite for treatment with Piqray® (aplelisib), a new therapy from Novartis for the treatment of postmenopausal women and all men with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-), PIK3CA-mutated, advanced or metastatic breast cancer, as detected by an FDA-approved test following progression on or after an endocrine-based regimen.

  • PR Newswire2 months ago

    Faruqi & Faruqi, LLP is Investigating Laboratory Corporation of America Holdings (LH) on Behalf of its Shareholders

    NEW YORK , June 6, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Laboratory Corporation of America Holdings ("LabCorp" ...

  • Reuters2 months ago

    UPDATE 1-Opko Health says over 400,000 customers likely affected by data breach

    Opko Health Inc said on Thursday it was notified by its former billing collections vendor about unauthorized access to information on about 422,600 customers, making it the third healthcare company to be affected by the incident. American Medical Collection Agency (AMCA) informed Opko Health that the compromised data may include credit card and bank account information, email addresses and other data such as address, phone number and balance information. Earlier this week, rivals Quest Diagnostics Inc and Laboratory Corporation of America Holdings also announced that they were apprised of unauthorized access to their customer data stored on AMCA system.

  • King: 'No conceivable set of circumstances' in which LabCorp leaves Triad
    American City Business Journals2 months ago

    King: 'No conceivable set of circumstances' in which LabCorp leaves Triad

    On Wednesday, King announced his retirement as president and CEO of the Burlington-based life sciences firm.

  • Daily Crunch: Peloton files to go public
    TechCrunch2 months ago

    Daily Crunch: Peloton files to go public

    The Daily Crunch is TechCrunch's roundup of our biggest and most important stories. The company, which has been valued at $4 billion, paved the way for a variety of home fitness companies. YouTube has told a reporter at Vox that the comments made by a prominent conservative channel (describing the reporter as as "lispy queer" and "the gay Latino host at Vox") do not violate its policies.